Candriam S.C.A. Treace Medical Concepts, Inc. Transaction History

Candriam S.C.A.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	BUY	$11.48 - $15.86 $1.2 Million - $1.66 Million	104,945 Added 29.98%	454,945 $5.94 Million
Q4 2023 Feb 14, 2024	SELL	$6.03 - $12.88 $470,171 - $1 Million	-77,972 Reduced 18.22%	350,000 $4.46 Million
Q3 2023 Nov 13, 2023	BUY	$12.16 - $24.87 $4.35 Million - $8.9 Million	357,972 Added 511.39%	427,972 $5.61 Million
Q2 2023 Aug 08, 2023	BUY	$23.91 - $27.81 $1.67 Million - $1.95 Million	70,000 New	70,000 $1.79 Million
Q2 2022 Aug 03, 2022	BUY	$12.93 - $20.29 $258,600 - $405,800	20,000 Added 23.53%	105,000 $1.51 Million
Q1 2022 May 13, 2022	BUY	$16.73 - $21.58 $886,690 - $1.14 Million	53,000 Added 165.63%	85,000 $1.61 Million
Q3 2021 Nov 09, 2021	BUY	$24.15 - $30.5 $289,800 - $366,000	12,000 Added 60.0%	32,000 $861,000
Q2 2021 Jul 20, 2021	BUY	$25.53 - $36.11 $510,600 - $722,200	20,000 New	20,000 $625,000

137

39.6M

248K

269K

Ticker TMCI
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 55,403,300
Market Cap $423M
Description
Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical impro...

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

Stay updated on Candriam S.C.A. with notifications on news.